Can we avoid acquisition of drug resistance in cancer?
Work in our lab by @prasi333 shows that cells in culture acquire resistance to MEKi Selumetinib through impaired cell cycling during treatment
https://t.co/Q3hc4r00LJ
Great collaboration with @DrSimonCook1 and @AstraZeneca